FDA Commissioner Faces Pressure To Limit Abortion Pill After Study Finds Increased Risks
U.S. Food and Drug Administration Commissioner Martin Makary’s deeply rooted belief in data-based decision making could be put to the test after a new study found that mifepristone, the drug responsible for more than half of the nation’s…